Starpharma Holdings Limited
SPHRY · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $36 | $37 | $129 | $280 |
| - Cash | $15 | $23 | $35 | $50 |
| + Debt | $2 | $4 | $8 | $8 |
| Enterprise Value | $23 | $17 | $102 | $238 |
| Revenue | $6 | $8 | $4 | $5 |
| % Growth | -29.4% | 90.9% | -15.9% | – |
| Gross Profit | -$4 | $8 | $1 | $2 |
| % Margin | -63.7% | 92.4% | 28.1% | 36.9% |
| EBITDA | -$10 | -$10 | -$17 | -$16 |
| % Margin | -166.2% | -116.2% | -392.4% | -306% |
| Net Income | -$10 | -$8 | -$16 | -$16 |
| % Margin | -170.8% | -98.5% | -360.1% | -312.9% |
| EPS Diluted | -0.24 | -0.2 | -0.38 | -0.4 |
| % Growth | -20% | 47.4% | 5% | – |
| Operating Cash Flow | -$7 | -$7 | -$14 | -$13 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$1 |
| Free Cash Flow | -$7 | -$7 | -$14 | -$14 |